Fight against treatment-resistant superbugs

Researchers are studying the genes of superbugs to aid the development of new and effective treatments for drug-resistant […]

Institute of Cancer Research embraces olaparib recommendation

Vital AstraZeneca therapy may transform lives of people with certain breast and prostate cancers

Positive study results for Infex’s RESP-X

Data demonstrates a sound safety and tolerability profile for therapy during phase 1 clinical trial

PANCREAS LIQUESCENCE (cinnamomum, gymnema sylvestre, phosphoricum acidum, syzygium jambolanum, trigonella foenum-graceum, argentum nitricum, chionanthus virginica, hepar suis, pancreas suis, rhus aromatica, sulphur, lycopodium clavatum, chromium picolinate, chromium metallicum, phosphorus, vanadium metallicum, zincum metallicum, murex purpurea, dna, insulinum (human), uranium nitricum) liquid [Nutritional Specialties, Inc.]

Updated Date: Wed, 29 Mar 2023 00:00:00 EDT

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE syrup [Padagis US LLC]

Updated Date: Wed, 29 Mar 2023 00:00:00 EDT

ASMANEX HFA (mometasone furoate) aerosol [Organon LLC]

Updated Date: Wed, 29 Mar 2023 00:00:00 EDT

FUROSEMIDE (furosemide) tablet [Bryant Ranch Prepack]

Updated Date: Wed, 29 Mar 2023 00:00:00 EDT

ALLERGY RELIEF (diphenhydramine hcl) tablet [P & L Development, LLC]

Updated Date: Wed, 29 Mar 2023 00:00:00 EDT

Ipsen reacts to NICE’s Cabometyx verdict

Company disappointed by institute’s failure to recommend thyroid cancer therapy for specific patient group

Avacta doses first patient in pivotal phase 1a trial

Individual receives AVA6000 treatment as part of additional dose escalating study